» Articles » PMID: 25285959

Structural and Energetic Effects of A2A Adenosine Receptor Mutations on Agonist and Antagonist Binding

Overview
Journal PLoS One
Date 2014 Oct 7
PMID 25285959
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

To predict structural and energetic effects of point mutations on ligand binding is of considerable interest in biochemistry and pharmacology. This is not only useful in connection with site-directed mutagenesis experiments, but could also allow interpretation and prediction of individual responses to drug treatment. For G-protein coupled receptors systematic mutagenesis has provided the major part of functional data as structural information until recently has been very limited. For the pharmacologically important A(2A) adenosine receptor, extensive site-directed mutagenesis data on agonist and antagonist binding is available and crystal structures of both types of complexes have been determined. Here, we employ a computational strategy, based on molecular dynamics free energy simulations, to rationalize and interpret available alanine-scanning experiments for both agonist and antagonist binding to this receptor. These computer simulations show excellent agreement with the experimental data and, most importantly, reveal the molecular details behind the observed effects which are often not immediately evident from the crystal structures. The work further provides a distinct validation of the computational strategy used to assess effects of point-mutations on ligand binding. It also highlights the importance of considering not only protein-ligand interactions but also those mediated by solvent water molecules, in ligand design projects.

Citing Articles

Ligand and Residue Free Energy Perturbations Solve the Dual Binding Mode Proposal for an AAR Partial Agonist.

Tandaric T, Gutierrez-de-Teran H J Phys Chem B. 2025; 129(3):886-899.

PMID: 39772736 PMC: 11770768. DOI: 10.1021/acs.jpcb.4c07391.


Alchemical Free Energy Calculations on Membrane-Associated Proteins.

Papadourakis M, Sinenka H, Matricon P, Henin J, Brannigan G, Perez-Benito L J Chem Theory Comput. 2023; 19(21):7437-7458.

PMID: 37902715 PMC: 11017255. DOI: 10.1021/acs.jctc.3c00365.


Molecular Simulations and Drug Discovery of Adenosine Receptors.

Wang J, Bhattarai A, Do H, Akhter S, Miao Y Molecules. 2022; 27(7).

PMID: 35408454 PMC: 9000248. DOI: 10.3390/molecules27072054.


Deciphering conformational selectivity in the A2A adenosine G protein-coupled receptor by free energy simulations.

Jespers W, Heitman L, IJzerman A, Sotelo E, van Westen G, Aqvist J PLoS Comput Biol. 2021; 17(11):e1009152.

PMID: 34818333 PMC: 8654218. DOI: 10.1371/journal.pcbi.1009152.


Identification of V6.51L as a selectivity hotspot in stereoselective A adenosine receptor antagonist recognition.

Wang X, Jespers W, Prieto-Diaz R, Majellaro M, IJzerman A, van Westen G Sci Rep. 2021; 11(1):14171.

PMID: 34238993 PMC: 8266863. DOI: 10.1038/s41598-021-93419-x.


References
1.
Hino T, Arakawa T, Iwanari H, Yurugi-Kobayashi T, Ikeda-Suno C, Nakada-Nakura Y . G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody. Nature. 2012; 482(7384):237-40. PMC: 3303121. DOI: 10.1038/nature10750. View

2.
Hess B, Kutzner C, van der Spoel D, Lindahl E . GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. J Chem Theory Comput. 2015; 4(3):435-47. DOI: 10.1021/ct700301q. View

3.
Tosh D, Phan K, Gao Z, Gakh A, Xu F, Deflorian F . Optimization of adenosine 5'-carboxamide derivatives as adenosine receptor agonists using structure-based ligand design and fragment screening. J Med Chem. 2012; 55(9):4297-308. PMC: 3479662. DOI: 10.1021/jm300095s. View

4.
Jaakola V, Griffith M, Hanson M, Cherezov V, Chien E, Lane J . The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science. 2008; 322(5905):1211-7. PMC: 2586971. DOI: 10.1126/science.1164772. View

5.
Gutierrez-de-Teran H . The roles of computational chemistry in the ligand design of G protein-coupled receptors: how far have we come and what should we expect?. Future Med Chem. 2014; 6(3):251-4. DOI: 10.4155/fmc.13.209. View